iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.7687
-0.0313 (-3.91%)
May 14, 2025, 1:30 PM - Market open
iBio, Inc. Stock Forecast
IBIO's stock price has decreased by -56.6% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for iBio, Inc. stock ranges from a low of $3.60 to a high of $6.00. The average analyst price target of $4.87 forecasts a 533.54% increase in the stock price over the next year.
Price Target: $4.87 (+533.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for iBio, Inc. stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +550.45% | May 6, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +550.45% | May 5, 2025 |
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +680.54% | Dec 17, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $3.6 | Strong Buy | Initiates | $3.6 | +368.32% | Jul 22, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +550.45% | Jun 3, 2024 |
Financial Forecast
Revenue This Year
306.00K
from 225.00K
Increased by 36.00%
Revenue Next Year
272.00K
from 306.00K
Decreased by -11.11%
EPS This Year
-1.62
from -6.50
EPS Next Year
-1.40
from -1.62
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 630,000 | 840,000 | n/a | ||
| Avg | 306,000 | 272,003 | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 180.0% | 174.5% | - | ||
| Avg | 36.0% | -11.1% | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.51 | -0.74 | -0.70 | ||
| Avg | -1.62 | -1.40 | -0.68 | ||
| Low | -1.71 | -2.01 | -0.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.